4th Pharmacovigilance, Risk Management & AER Conference, 6-7 May 2014, Philadelphia

Date: Mar-28-2014Developing Proactive Pharmacovigilance and Risk Management Strategies

Top Pharmaceutical and Biotech Representatives to Discuss the Current Complexities and Key Challenges in Pharmacovigilance, May 6-7, 2014 in Philadelphia, PA.

marcus evans will host the 4th Pharmacovigilance, Risk Management & AER Conference, May 6-7, 2014 in Philadelphia, PA.

The meeting will address many pressing concerns regarding drug safety, including effectively identifying and managing potential risks and ensuring a balanced benefit-risk ratio. Top pharmaceutical and biotech representatives will discuss the current complexities and key challenges in pharmacovigilance and risk management throughout the product lifecycle.

Featuring Case Studies from Leading Pharmacovigilance Experts, including:

Katie Clifford, MBA, BSN, RN, Director, Drug Safety & Public Health, Gilead Sciences

Greg Pawell, Assistant Director, Medical Safety Evaluation, AbbVie

Jennifer Reinert, Senior Manager, Risk Management, Pfizer

Muneet Burke, MD, Director, Global Medical Safety, Janssen, Pharmaceutical Companies of Johnson and Johnson

Hot topics, such as the use of social media in signal detection and the role of pharmacovigilance across the product lifecycle will be discussed as well. In addition, attendees will have the opportunity to engage in meaningful conversations with their peers who are dealing with many of the same issues involved with pharmacovigilance, risk management, and adverse event reporting.

For more information on this conference & to get a complete list of speakers or sessions, click on the conference brochure or email Tyler Kelch, Marketing & PR Coordinator at tylerke@marcusevansch.com

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.